Fusen Pharmaceutical Company Limited (HKG:1652)

HKG:1652 Statistics

Total Valuation

HKG:1652 has a market cap or net worth of HKD 247.67 million. The enterprise value is 637.08 million.

Market Cap	247.67M
Enterprise Value	637.08M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1652 has 739.30 million shares outstanding. The number of shares has decreased by -1.60% in one year.

Current Share Class	739.30M
Shares Outstanding	739.30M
Shares Change (YoY)	-1.60%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	20.92%
Owned by Institutions (%)	0.01%
Float	193.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.71
PB Ratio	0.63
P/TBV Ratio	0.68
P/FCF Ratio	3.20
P/OCF Ratio	1.74
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.17
EV / Sales	1.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	8.23

Financial Position

The company has a current ratio of 0.60, with a Debt / Equity ratio of 1.05.

Current Ratio	0.60
Quick Ratio	0.36
Debt / Equity	1.05
Debt / EBITDA	n/a
Debt / FCF	5.34
Interest Coverage	-3.34

Financial Efficiency

Return on equity (ROE) is -40.58% and return on invested capital (ROIC) is -5.04%.

Return on Equity (ROE)	-40.58%
Return on Assets (ROA)	-3.25%
Return on Invested Capital (ROIC)	-5.04%
Return on Capital Employed (ROCE)	-14.42%
Revenue Per Employee	306,765
Profits Per Employee	-177,628
Employee Count	1,131
Asset Turnover	0.25
Inventory Turnover	0.97

Taxes

Income Tax	-1.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.99% in the last 52 weeks. The beta is 0.26, so HKG:1652's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-66.99%
50-Day Moving Average	0.35
200-Day Moving Average	0.56
Relative Strength Index (RSI)	41.08
Average Volume (20 Days)	108,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1652 had revenue of HKD 346.95 million and -200.90 million in losses. Loss per share was -0.27.

Revenue	346.95M
Gross Profit	173.07M
Operating Income	-71.49M
Pretax Income	-202.67M
Net Income	-200.90M
EBITDA	-34.59M
EBIT	-71.49M
Loss Per Share	-0.27

Balance Sheet

The company has 22.41 million in cash and 413.22 million in debt, giving a net cash position of -390.81 million or -0.53 per share.

Cash & Cash Equivalents	22.41M
Total Debt	413.22M
Net Cash	-390.81M
Net Cash Per Share	-0.53
Equity (Book Value)	392.00M
Book Value Per Share	0.53
Working Capital	-332.91M

Cash Flow

In the last 12 months, operating cash flow was 142.31 million and capital expenditures -64.87 million, giving a free cash flow of 77.44 million.

Operating Cash Flow	142.31M
Capital Expenditures	-64.87M
Free Cash Flow	77.44M
FCF Per Share	0.10

Margins

Gross margin is 49.88%, with operating and profit margins of -20.60% and -57.90%.

Gross Margin	49.88%
Operating Margin	-20.60%
Pretax Margin	-58.41%
Profit Margin	-57.90%
EBITDA Margin	-9.97%
EBIT Margin	-20.60%
FCF Margin	22.32%

Dividends & Yields

HKG:1652 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.60%
Shareholder Yield	n/a
Earnings Yield	-81.12%
FCF Yield	31.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1652 has an Altman Z-Score of 0.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.39
Piotroski F-Score	3